Narihito Nagoshi
Overview
Explore the profile of Narihito Nagoshi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
285
Citations
3927
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maki S, Shiratani Y, Orita S, Suzuki A, Tamai K, Shimizu T, et al.
Spine (Phila Pa 1976)
. 2025 Mar;
PMID: 40085125
Study Design: Retrospective analysis of data collected across multiple centers. Objective: To develop machine learning models for predicting neurological outcomes one month postoperatively in patients with metastatic spinal tumors undergoing...
2.
Sugai K, Nakamura M, Okano H, Nagoshi N
Brain Spine
. 2025 Mar;
5:104207.
PMID: 40027291
Recently, cell transplantation has emerged as a promising treatment for spinal cord injury (SCI). Over the past decade, numerous clinical studies of SCI have been conducted using various types of...
3.
Kitazawa S, Nagoshi N, Okita H, Suzuki S, Ozaki M, Takahashi Y, et al.
Spine Surg Relat Res
. 2025 Feb;
9(1):104-107.
PMID: 39935978
No abstract available.
4.
Lou Z, Post A, Nagoshi N, Hong J, Hejrati N, Chio J, et al.
Stem Cells Transl Med
. 2025 Feb;
14(2).
PMID: 39931999
Regenerative therapies are currently lacking for spinal cord injury (SCI). Neural progenitor cells (NPCs) have emerged as a promising therapeutic approach. To facilitate translation of NPCs into the clinic, studying...
5.
Matsuo T, Kimura H, Nishijima T, Kiyota Y, Suzuki T, Nagoshi N, et al.
Sci Rep
. 2025 Jan;
15(1):3797.
PMID: 39885362
While silk fibroin (SF) obtained from silkworm cocoons is expected to become a next-generation natural polymer, a fabrication method for SF-based artificial nerve conduits (SFCs) has not yet been established....
6.
Zhang L, Yamada S, Nagoshi N, Shinozaki M, Tsuji T, Nakamura M, et al.
Ann Phys Rehabil Med
. 2025 Jan;
68(3):101911.
PMID: 39798215
Background: Despite the lack of clinically validated strategies for treating spinal cord injury (SCI), combining therapeutic strategies with rehabilitation is believed to promote recovery of motor function; however, current research...
7.
Okawara H, Sawada T, Onuki S, Sugai K, Okubo T, Ozaki M, et al.
Neurol Sci
. 2024 Dec;
PMID: 39739273
Objective: To determine the effects of exercise on trunk performance and balance in patients with spinal cord injury (SCI). Methods: We searched the databases MEDLINE, Cochrane Library, EMBASE, Physiotherapy Evidence...
8.
Ito K, Shinozaki M, Hashimoto S, Saijo Y, Suematsu Y, Tanaka T, et al.
Sci Rep
. 2024 Dec;
14(1):31500.
PMID: 39733145
Chronic complete spinal cord injury (SCI) is difficult to treat because of scar formation and cavitary lesions. While human iPS cell-derived neural stem/progenitor cell (hNS/PC) therapy shows promise, its efficacy...
9.
Nagoshi N, Okubo T, Ozaki M, Suzuki S, Takeda K, Iga T, et al.
Spinal Cord
. 2024 Dec;
63(2):75-79.
PMID: 39672822
Study Design: Retrospective cohort study. Objectives: Due to the rarity of intradural spinal tumors (ISTs) in individuals under 20, comprehensive studies are lacking. This study aims to compare the clinical...
10.
Fukase Y, Watanabe K, Takeda K, Okubo T, Suzuki S, Tsuji O, et al.
Spine Surg Relat Res
. 2024 Dec;
8(6):654-658.
PMID: 39659376
No abstract available.